MedTrace Logo

Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns

NCT06329388 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-03-26

No results posted yet for this study

Summary

This single-center, randomized controlled pilot study aims to evaluate the efficacy of TruHeight Growth Protein Shake on improving growth patterns in children aged 4-17 years. Over six months, participants will consume the protein shake daily, five times a week, with outcomes measured in terms of type X collagen concentration in urine, height via a stadiometer, and body composition using an INBODY device.

Conditions

  • Growth Disorders
  • Dietary Exposure
  • Child Development
  • Bone Development Abnormal
  • Body Weight
  • Child Malnutrition

Interventions

DIETARY_SUPPLEMENT

TruHeight Growth Protein Shake

Participants will be administered two scoops of TruHeight Growth Protein Shake, mixed with 12-16 fluid ounces of water, once daily, five times per week for six months. The supplement is intended to support growth patterns in children by providing essential nutrients that contribute to bone development and overall growth.

Sponsors & Collaborators

  • San Francisco Research Institute

    collaborator UNKNOWN

  • TruHeight Vitamins

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-18
Primary Completion
2023-07-07
Completion
2023-08-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06329388 on ClinicalTrials.gov